Blueprint Medicines Corporation(BPMC)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BPMC Blueprint Medicines Corporation

休市中 05-02 16:00:00 EDT

104.64

+5.39

+5.43%

盘后104.64

+0.000.00%

19:38 EDT

最高104.86	最低98.60	成交量151.42万
今开99.25	昨收99.25	日振幅6.31%
总市值67.57亿	流通市值66.80亿	总股本6,458万
成交额1.56亿	换手率2.37%	流通股本6,384万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"BPMC","market":"US","secType":"STK","nameCN":"Blueprint Medicines Corporation","latestPrice":104.64,"timestamp":1746216000000,"preClose":99.25,"halted":0,"volume":1514216,"hourTrading":{"tag":"盘后","latestPrice":104.64,"preClose":104.64,"latestTime":"19:38 EDT","volume":6581,"amount":688634.48,"timestamp":1746229135148},"delay":0,"floatShares":63836781,"shares":64575904,"eps":-1.067327,"marketStatus":"休市中","change":5.39,"latestTime":"05-02 16:00:00 EDT","open":99.25,"high":104.86,"low":98.595,"amount":155605878.49928,"amplitude":0.063123,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.067327,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1746432000000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1430366400000,"exchange":"NASDAQ","adjPreClose":99.25,"preHourTrading":{"tag":"盘前","latestPrice":96.71,"preClose":99.25,"latestTime":"09:25 EDT","volume":400,"amount":39702.832,"timestamp":1746192300051},"postHourTrading":{"tag":"盘后","latestPrice":104.64,"preClose":104.64,"latestTime":"19:38 EDT","volume":6581,"amount":688634.48,"timestamp":1746229135148},"volumeRatio":1.556598439756134,"impliedVol":0.4678,"impliedVolPercentile":0.216},"requestUrl":"/m/hq/s/BPMC/tweets","defaultTab":"tweets","newsList":[{"id":"1182155593","title":"异动解读 | 蓝图医药股价盘中大涨5.01%，分析师保持看好态度","url":"https://stock-news.laohu8.com/highlight/detail?id=1182155593","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1182155593?lang=zh_cn&edition=full","pubTime":"2025-05-03 03:43","pubTimestamp":1746214980,"startTime":"0","endTime":"0","summary":"周五盘中，生物制药公司蓝图医药股价出现显著上涨，涨幅高达5.01%，引发市场关注。此外，公司还有多个处于研发阶段的药物候选者，如BLU-808、BLU-222和BLU-956等，旨在治疗包括SM和慢性荨麻疹、乳腺癌及其他实体肿瘤在内的多种疾病。股价上涨的背后，可能与分析师的积极评级有关。此外，生物技术行业整体表现良好，也可能对蓝图医药的股价产生积极影响。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | 蓝图医药股价盘中大涨5.01%，分析师保持看好态度","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["BPMC"],"gpt_icon":0},{"id":"2532844669","title":"Blueprint Medicines Corporation涨0.94% 股价突破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2532844669","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532844669?lang=zh_cn&edition=full","pubTime":"2025-05-02 21:32","pubTimestamp":1746192733,"startTime":"0","endTime":"0","summary":"北京时间2025年05月02日21时32分，Blueprint Medicines Corporation股票出现波动，股价大幅拉升0.94%。Blueprint Medicines Corporation股票所在的生物技术行业中，整体涨幅为1.33%。Blueprint Medicines Corporation公司简介：蓝图医药公司是一家生物制药公司。消息层面，截至21时32分，《Needham：维持Blueprint Medicines评级，由买入调整至买入评级, 目标价由133.00美元调整至130.00美元。》资讯为影响Blueprint Medicines Corporation的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050221321394eac25a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050221321394eac25a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","LU0053671581.USD","BPMC"],"gpt_icon":0},{"id":"1127263080","title":"异动解读 | Blueprint Medicines盘中大涨5.06%，尽管季度亏损超预期但收入大幅增长","url":"https://stock-news.laohu8.com/highlight/detail?id=1127263080","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1127263080?lang=zh_cn&edition=full","pubTime":"2025-05-01 21:48","pubTimestamp":1746107319,"startTime":"0","endTime":"0","summary":"生物技术公司Blueprint Medicines Corporation今日盘中股价大涨5.06%，尽管公司公布的季度业绩显示亏损超出预期。这一涨幅引起了投资者的广泛关注。根据公司最新发布的财报，截至3月31日的季度，Blueprint Medicines调整后每股亏损74美分，高于分析师平均预期的53美分亏损。华尔街给予Blueprint Medicines未来12个月的目标价中位数为130.00美元，这可能也是支撑股价上涨的因素之一。公司在生物技术和医学研究领域的持续创新以及收入的快速增长，可能是投资者看好其未来发展的主要原因。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | Blueprint Medicines盘中大涨5.06%，尽管季度亏损超预期但收入大幅增长","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["BPMC"],"gpt_icon":0},{"id":"2532081480","title":"Blueprint Medicines Corporation盘中异动 早盘股价大涨5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2532081480","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532081480?lang=zh_cn&edition=full","pubTime":"2025-05-01 21:34","pubTimestamp":1746106490,"startTime":"0","endTime":"0","summary":"北京时间2025年05月01日21时34分，Blueprint Medicines Corporation股票出现异动，股价快速上涨5.28%。Blueprint Medicines Corporation股票所在的生物技术行业中，整体跌幅为1.51%。Blueprint Medicines Corporation公司简介：蓝图医药公司是一家生物制药公司。消息层面，截至21时34分，《Needham：维持Blueprint Medicines评级，由买入调整至买入评级, 目标价由133.00美元调整至130.00美元。》资讯为影响Blueprint Medicines Corporation的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501213451a46ef2db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501213451a46ef2db&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","LU0053671581.USD","BPMC"],"gpt_icon":0},{"id":"2531563112","title":"Needham：维持Blueprint Medicines评级，由买入调整至买入评级, 目标价由133.00美元调整至130.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2531563112","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531563112?lang=zh_cn&edition=full","pubTime":"2025-04-29 01:53","pubTimestamp":1745862787,"startTime":"0","endTime":"0","summary":"Needham：维持Blueprint Medicines(BPMC.US)评级，由买入调整至买入评级, 目标价由133.00美元调整至130.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042901574794e6344a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042901574794e6344a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BPMC"],"gpt_icon":0},{"id":"2517673394","title":"Blueprint Medicines(BPMC.US)获Scotiabank首次覆盖，给予跑赢大盘评级, 目标价150.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517673394","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517673394?lang=zh_cn&edition=full","pubTime":"2025-03-08 06:57","pubTimestamp":1741388258,"startTime":"0","endTime":"0","summary":"Blueprint Medicines(BPMC.US)获Scotiabank首次覆盖，给予跑赢大盘评级, 目标价150.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/08065748605351.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BPMC"],"gpt_icon":0},{"id":"2516656312","title":"Blueprint Medicines Corporation盘中异动 大幅下跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516656312","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516656312?lang=zh_cn&edition=full","pubTime":"2025-03-04 00:58","pubTimestamp":1741021132,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日00时58分，Blueprint Medicines Corporation股票出现波动，股价快速下挫5.01%。Blueprint Medicines Corporation股票所在的生物技术行业中，整体涨幅为0.06%。其相关个股中，Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Estrella Immunopharma Inc C/Wts 29/09/2028涨幅较大，Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为4038.79%、175.52%、144.04%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Entero Therapeutics Inc.，振幅分别为206.20%、119.50%、70.53%。Blueprint Medicines Corporation公司简介：蓝图医药公司是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304005853abe6602f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304005853abe6602f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0053671581.USD","BK4505","BPMC","BK4139"],"gpt_icon":0},{"id":"2516064573","title":"Blueprint Medicines Corporation盘中异动 下午盘股价大涨5.01%报94.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516064573","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516064573?lang=zh_cn&edition=full","pubTime":"2025-03-01 04:06","pubTimestamp":1740773213,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日04时06分，Blueprint Medicines Corporation股票出现异动，股价急速上涨5.01%。Blueprint Medicines Corporation股票所在的生物技术行业中，整体涨幅为0.42%。其相关个股中，Bioxcel Therapeutics, Inc.、Enveric Biosciences, Inc.、Camp4 Therapeutics Corporation涨幅较大，Bioxcel Therapeutics, Inc.、Enveric Biosciences, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为3256.20%、593.34%、393.82%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 ，振幅分别为57.80%、49.90%、48.19%。Blueprint Medicines Corporation公司简介：蓝图医药公司是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301040653abe13617&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301040653abe13617&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","BPMC","LU0053671581.USD"],"gpt_icon":0},{"id":"2512955683","title":"Blueprint Medicines Corporation2024财年实现净利润-67.09百万美元，同比增加86.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512955683","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512955683?lang=zh_cn&edition=full","pubTime":"2025-02-17 00:01","pubTimestamp":1739721670,"startTime":"0","endTime":"0","summary":"2月17日，Blueprint Medicines Corporation公布财报，公告显示公司2024财年净利润为-67.09百万美元，同比增加86.77%；其中营业收入为5.09亿美元，同比增加104.42%，每股基本收益为-1.07美元。从资产负债表来看，Blueprint Medicines Corporation总负债8.81亿美元，其中短期债务1.19亿美元，资产负债比为1.34，流动比率为2.85。机构评级：截至2025年2月17日，当前有19家机构对Blueprint Medicines Corporation目标价做出预测，其中目标均价为126.79美元，其中最低目标价为83.00美元，最高目标价为169.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250217000133abd1225b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250217000133abd1225b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BPMC"],"gpt_icon":0},{"id":"1140286726","title":"异动解读 | Blueprint Medicines公布2024年第四季度财报亏损超预期,引发盘中重挫8.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=1140286726","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1140286726?lang=zh_cn&edition=full","pubTime":"2025-02-13 23:09","pubTimestamp":1739459388,"startTime":"0","endTime":"0","summary":"Blueprint Medicines(BPMC)在盘中出现大幅下挫,最新报价96.93美元/股,较前一交易日下跌8.27%。\n\n公司前不久公布的2024年第四季度财报显示,第四季度每股亏损0.79美元,超出了分析师此前预计的0.70美元亏损。尽管公司当季销售额1.4637亿美元较去年同期翻番,但净亏损仍在扩大。\n\n业绩表现令投资者失望,加之公司定位于肿瘤及罕见病药物研发,现金流情况短期内难以改观,或是导致股价承压的主因。由于研发周期长、风险高,Blueprint Medicines未来的长期发展仍存在很大不确定性。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["BPMC"],"gpt_icon":0},{"id":"2511525113","title":"Blueprint Medicines Corporation盘中异动 股价大跌6.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511525113","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511525113?lang=zh_cn&edition=full","pubTime":"2025-02-13 22:32","pubTimestamp":1739457122,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日22时32分，Blueprint Medicines Corporation股票出现波动，股价急速下跌6.41%。截至发稿，该股报96.93美元/股，成交量7.7017万股，换手率0.12%，振幅2.18%。Blueprint Medicines Corporation股票所在的生物技术行业中，整体涨幅为0.17%。其相关个股中，Moleculin Biotech, Inc.、Edesa Biotech, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 涨幅较大，Tc Biopharm  Plc、Edesa Biotech, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为982.21%、804.75%、113.73%，振幅较大的相关个股有Moleculin Biotech, Inc.、Edesa Biotech, Inc.、Fibrobiologics, Inc.，振幅分别为30.00%、25.80%、16.18%。Blueprint Medicines Corporation公司简介：蓝图医药公司是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213223202abcdb249&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213223202abcdb249&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU0053671581.USD","BK4505","BPMC"],"gpt_icon":0},{"id":"1103683781","title":"Blueprint Medicines 2024年第四季度GAAP每股收益$(0.79) 低于估值$(0.70)，销售额$1.4637亿 超过预期$1.4584亿","url":"https://stock-news.laohu8.com/highlight/detail?id=1103683781","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1103683781?lang=zh_cn&edition=full","pubTime":"2025-02-13 20:06","pubTimestamp":1739448365,"startTime":"0","endTime":"0","summary":"Blueprint Medicines  公布的季度每股亏损为$，低于分析师普遍预期的$，差距为12.86%。这较去年同期每股亏损$增加了56.59%。公司报告的季度销售额为1.4637亿美元，超出分析师普遍预期的1.4584亿美元，超出0.36%。以上内容来自Benzinga Earnings专栏，原文如下：Blueprint Medicines  reported quarterly losses of $ per share which missed the analyst consensus estimate of $ by 12.86 percent. This is a 56.59 percent increase over losses of $ per share from the same period last year.  The company reported quarterly sales of $146.37 million which beat the analyst consensus estimate of $145.84 million by 0.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Blueprint Medicines 2024年第四季度GAAP每股收益$(0.79) 低于估值$(0.70)，销售额$1.4637亿 超过预期$1.4584亿","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BPMC"],"gpt_icon":0},{"id":"2509177678","title":"Blueprint Medicines Corporation盘中异动 股价大跌5.02%报104.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509177678","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509177678?lang=zh_cn&edition=full","pubTime":"2025-02-08 04:26","pubTimestamp":1738959979,"startTime":"0","endTime":"0","summary":"北京时间2025年02月08日04时26分，Blueprint Medicines Corporation股票出现异动，股价急速下跌5.02%。截至发稿，该股报104.12美元/股，成交量77.1732万股，换手率1.21%，振幅5.71%。Blueprint Medicines Corporation股票所在的生物技术行业中，整体跌幅为0.80%。其相关个股中，Conduit Pharmaceuticals Inc.、Surrozen Inc C/Wts 01/08/2031 、Sionna Therapeutics, Inc.涨幅较大，Conduit Pharmaceuticals Inc.、Tonix Pharmaceuticals Holding Corp.、Lipella Pharmaceuticals Inc.较为活跃，换手率分别为9017.21%、184.31%、165.76%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Conduit Pharmaceuticals Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 ，振幅分别为130.43%、93.55%、66.67%。Blueprint Medicines Corporation公司简介：蓝图医药公司是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208042619abc6750b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208042619abc6750b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU0053671581.USD","BK4505","BPMC"],"gpt_icon":0},{"id":"2508746891","title":"小摩：维持Blueprint Medicines(BPMC.US)评级，由增持调整至增持评级, 目标价由126.00美元调整至129.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2508746891","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508746891?lang=zh_cn&edition=full","pubTime":"2025-02-04 23:13","pubTimestamp":1738681987,"startTime":"0","endTime":"0","summary":"小摩：维持Blueprint Medicines(BPMC.US)评级，由增持调整至增持评级, 目标价由126.00美元调整至129.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/04231347949906.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BPMC"],"gpt_icon":0},{"id":"2504449484","title":"特朗普2.0时代即将开启，投资机会如何掘金？","url":"https://stock-news.laohu8.com/highlight/detail?id=2504449484","media":"招商基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504449484?lang=zh_cn&edition=full","pubTime":"2025-01-20 10:36","pubTimestamp":1737340585,"startTime":"0","endTime":"0","summary":"美国候任总统唐纳德·特朗普将于美东时间1月20日12时正式宣誓就任美国第47任总统。特朗普2.0时代即将开启，有哪些投资机会可以布局？值得一提的是，科技股在特朗普任期内表现尤为突出，成为推动美股上涨的主要力量。在特朗普第一个任期内，美元整体表现相对弱势。4年任期内，美元指数累计下跌了10.53%。而纵观全球市场，在特朗普上一任期内，恒生科技指数涨幅超过147%，表现甚至略微优于纳斯达克指数。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250120103318abb12e8e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250120103318abb12e8e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HSIC","OTEX","PCAR","BK4581","MIDD","NBIX","PDD","CSCO","MPWR","QLD","PFG","MELI","BMRN","LKQ","MTCH","COKE","OKTA","TMUS","AMD","MKSI","ITCI","ROKU","HBAN","LU0757428866.USD","ASML","ILMN","TROW","AVGO","WYNN","DSGX","ENTG","PSQ","FOX","GTLB","LOGI","LULU","GNTX","RPRX","ALAB","MDB","WWD","CBSH","TPG","MNDY","DOX","TTEK","NVDA","CHKP","AAON","META",".IXIC","ADI","PLTR","EQIX","INTC","JKHY","AZN","CHDN","ADSK","DOCU","PARA","BKR","EWBC","MNQmain","BPOP","BK4585","NQmain","FYBR","MSFT","NTRS","NTAP","ODFL","ONC","FER","ORLY","MRVL","PCVX","REG","HOLX","CHRW","CCEP","HLNE","ROST","BK4534","CRWD","GEN","MKTX","SNPS","RADX","NVMI","ERIC","TQQQ","Z","FAST","OLED","SIRI","BK4561","WBA","ZM","BK4086","LAMR","KHC","ALNY","EXPE","ARM","PTC","ESLT","SWKS","TER","MMYT","TSEM","CSX","AMGN","SEIC","NICE","CME","ZS","HOOD","ADBE","AUR","COIN","GILD","QQQ","HQY","CWST","PCTY","TLN","CG","ROP","SOFI","AKAM","ALGN","CINF","COO","WTFC","INTU","FWONK","LSTR","PNFP","CSWI","DLTR","HON","INCY","NDAQ","ROIV","SBUX","NVIW.SI","FRPT","CTAS","USAW.SI","AGNC","QRVO","CFLT","CYBR","SMCI","BPMC","SQQQ","DPZ","TXN","CHRD","GOOGL","FSV","BKNG","SAIA","JD","AFRM","NFLX","NWSA","SFM","COST","REGN","ENPH","RIVN","PAYX","LU0053671581.USD","FCNCA","QCOM","CSGP","ON","AAL","NTRA","NXPI","GRAB","RGLD","CEG","CDW","DUOL","LI","POOL","SBAC","SSNC","LNW","FOXA","ERIE","STLD","IDXX","BSY","LPLA","EVRG","LU2065731478.USD","CDNS","RGEN","ISRG","EBAY","PEP","CTSH","FTAI","RYAAY","HST","STX","TTWO","DDOG","MRNA","PODD","RVMD","DKNG","MARA","PAA","QID","SRPT","NTNX","TSYW.SI","INSM","TW","FTNT","CASY","TECH","MDLZ","KDP","CPB","GEHC","ICLR","MANH","TSLA","GMAB","USJW.SI","WDC","AMZN","LU1815336091.USD","TRMB","MEDP","ULTA","EXAS","BRKR","DASH","AEP","APA","CZR","AXON","BK4593","CHTR","LIN","LNT","MNST","EXE","NTES","QXO","JBHT","GLPI","TSCO","BK4588","EA","BK4550","MTSI","LECO","AMAT","ARGX","LSCC","MCHP","TEAM","AAPL","TTD","CPRT","FFIV","TCOM","HTHT","NDSN","RKLB","ANSS","FSLR","BIIB"],"gpt_icon":1},{"id":"2504115141","title":"Blueprint Medicines Corporation盘中异动 股价大涨5.05%报109.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2504115141","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504115141?lang=zh_cn&edition=full","pubTime":"2025-01-18 03:08","pubTimestamp":1737140898,"startTime":"0","endTime":"0","summary":"北京时间2025年01月18日03时08分，Blueprint Medicines Corporation股票出现异动，股价大幅上涨5.05%。截至发稿，该股报109.20美元/股，成交量36.5888万股，换手率0.58%，振幅4.12%。Blueprint Medicines Corporation股票所在的生物技术行业中，整体涨幅为0.47%。Blueprint Medicines Corporation公司简介：蓝图医药公司是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250118030818986a4e56&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250118030818986a4e56&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0053671581.USD","BK4505","BPMC","BK4139"],"gpt_icon":0},{"id":"2503621151","title":"Blueprint Medicines Corporation盘中异动 快速上涨5.05%报107.74美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503621151","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503621151?lang=zh_cn&edition=full","pubTime":"2025-01-16 00:22","pubTimestamp":1736958167,"startTime":"0","endTime":"0","summary":"北京时间2025年01月16日00时22分，Blueprint Medicines Corporation股票出现异动，股价大幅拉升5.05%。截至发稿，该股报107.74美元/股，成交量32.907万股，换手率0.52%，振幅2.94%。Blueprint Medicines Corporation股票所在的生物技术行业中，整体涨幅为0.94%。Blueprint Medicines Corporation公司简介：蓝图医药公司是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501160022489604cf0f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501160022489604cf0f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","LU0053671581.USD","BPMC"],"gpt_icon":0},{"id":"2503958390","title":"Blueprint Medicines Corporation盘中异动 大幅上涨5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503958390","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503958390?lang=zh_cn&edition=full","pubTime":"2025-01-13 22:31","pubTimestamp":1736778664,"startTime":"0","endTime":"0","summary":"北京时间2025年01月13日22时31分，Blueprint Medicines Corporation股票出现波动，股价快速拉升5.23%。截至发稿，该股报92.00美元/股，成交量2.1354万股，换手率0.03%，振幅2.02%。Blueprint Medicines Corporation股票所在的生物技术行业中，整体跌幅为1.01%。其相关个股中，Salarius Pharmaceuticals, Inc.、Phio Pharmaceuticals Corp.、Kairos Pharma, Ltd.涨幅较大，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为2482.79%、1565.55%、388.89%，振幅较大的相关个股有In8Bio, Inc.、天境生物、Aditxt, Inc.，振幅分别为108.13%、106.67%、105.36%。Blueprint Medicines Corporation公司简介：蓝图医药公司是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011322310496025287&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011322310496025287&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","LU0053671581.USD","BPMC"],"gpt_icon":0},{"id":"2501733318","title":"Blueprint Medicines Corporation盘中异动 快速拉升5.08%报94.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2501733318","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501733318?lang=zh_cn&edition=full","pubTime":"2025-01-08 02:05","pubTimestamp":1736273130,"startTime":"0","endTime":"0","summary":"北京时间2025年01月08日02时05分，Blueprint Medicines Corporation股票出现异动，股价大幅拉升5.08%。截至发稿，该股报94.09美元/股，成交量18.9323万股，换手率0.30%，振幅4.29%。Blueprint Medicines Corporation股票所在的生物技术行业中，整体涨幅为1.10%。Blueprint Medicines Corporation公司简介：蓝图医药公司是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010802053095fbc282&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010802053095fbc282&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BPMC","BK4505","BK4139","LU0053671581.USD"],"gpt_icon":0},{"id":"2492159694","title":"Blueprint Medicines Corporation盘中异动 临近收盘急速下跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492159694","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492159694?lang=zh_cn&edition=full","pubTime":"2024-12-19 04:43","pubTimestamp":1734554590,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日04时43分，Blueprint Medicines Corporation股票出现波动，股价急速跳水5.05%。截至发稿，该股报91.61美元/股，成交量60.3382万股，换手率0.95%，振幅6.94%。Blueprint Medicines Corporation股票所在的生物技术行业中，整体跌幅为2.98%。其相关个股中，Polyrizon Ltd.、Tc Biopharm  Plc C/Wts 10/02/2028 、Surrozen Inc C/Wts 01/08/2031 涨幅较大，Polyrizon Ltd.、Cognition Therapeutics, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为3231.39%、679.46%、351.24%，振幅较大的相关个股有Polyrizon Ltd.、Cognition Therapeutics, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025，振幅分别为227.62%、151.66%、105.17%。Blueprint Medicines Corporation公司简介：蓝图医药公司是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219044310a1f958d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219044310a1f958d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BPMC","LU0053671581.USD","BK4505"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.blueprintmedicines.com","stockEarnings":[{"period":"1week","weight":0.1937},{"period":"1month","weight":0.1625},{"period":"3month","weight":-0.0701},{"period":"6month","weight":0.1537},{"period":"1year","weight":-0.0221},{"period":"ytd","weight":0.1997}],"compareEarnings":[{"period":"1week","weight":0.0293},{"period":"1month","weight":0.004},{"period":"3month","weight":-0.0583},{"period":"6month","weight":-0.0075},{"period":"1year","weight":0.1222},{"period":"ytd","weight":-0.033}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"蓝图医药公司于2008年10月14日在特拉华州成立，是一家生物制药公司，专注于改善患者的异常活化蛋白激酶基因组驱动的疾病定义的生命。该公司的做法是系统性和可重复鉴定激酶是基因组疾病定义驱动器和手艺的候选药物与治疗窗户，提供显著和持久的临床反应的患者。该公司正致力于几乎所有的努力研发，最初的市场开发，提高资本。该公司是受一些风险相似的其他早期阶段的公司，包括关键个人的依赖;需要开发商业上可行的药物;其他公司，其中有许多是更大和更好的资本竞争;并需要获得足够的额外资金，其药物的开发提供资金。如果公司无法筹集资金需要时或有吸引力的条件，这将被迫推迟，减少，消除或超出许可它的某些研究和开发项目或今后的商业化努力。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.021421},{"month":2,"riseRate":0.6,"avgChangeRate":-0.00304},{"month":3,"riseRate":0.7,"avgChangeRate":0.03296},{"month":4,"riseRate":0.4,"avgChangeRate":-0.01942},{"month":5,"riseRate":0.727273,"avgChangeRate":0.097546},{"month":6,"riseRate":0.6,"avgChangeRate":0.061595},{"month":7,"riseRate":0.7,"avgChangeRate":0.014145},{"month":8,"riseRate":0.7,"avgChangeRate":0.055409},{"month":9,"riseRate":0.6,"avgChangeRate":0.028138},{"month":10,"riseRate":0.4,"avgChangeRate":-0.027795},{"month":11,"riseRate":0.6,"avgChangeRate":0.051662},{"month":12,"riseRate":0.5,"avgChangeRate":0.031046}],"exchange":"NASDAQ","name":"Blueprint Medicines Corporation","nameEN":"Blueprint Medicines"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Blueprint Medicines Corporation(BPMC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Blueprint Medicines Corporation(BPMC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Blueprint Medicines Corporation,BPMC,Blueprint Medicines Corporation股票,Blueprint Medicines Corporation股票老虎,Blueprint Medicines Corporation股票老虎国际,Blueprint Medicines Corporation行情,Blueprint Medicines Corporation股票行情,Blueprint Medicines Corporation股价,Blueprint Medicines Corporation股市,Blueprint Medicines Corporation股票价格,Blueprint Medicines Corporation股票交易,Blueprint Medicines Corporation股票购买,Blueprint Medicines Corporation股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Blueprint Medicines Corporation(BPMC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Blueprint Medicines Corporation(BPMC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}